Artificial Intelligence | Machine Learning Circularis Biotechnologies | Circular RNA to Control any Gene


Enterprise, Biotechnology, Genetics, Medical, Therapeutics, Bioprocessing, Molecular Biology Oakland, CA, United States

Circularis Biotechnologies

Artificial Intelligence | Machine Learning


Circularis Biotechnologies | Circular RNA to Control any Gene

Circularis Biotechnologies

Biotechnology, Genetics, Medical, Therapeutics, Bioprocessing, Molecular Biology


Oakland, CA, United States

Control of any Gene in any Species or Cell Type. Circularis has used the power of circular RNA to develop a novel method to study and regulate gene expression. This technology has enabled increased bio-therapeutic production, improved targeting of gene therapy, and optimized expression in poorly studied organisms. The elegant design and high throughput nature of this technology enable breakthrough solutions without prior knowledge of the regulatory elements or coding sequence.

Promoters are the gatekeepers to controlling the cell. We seek to make a better world by forcing cells to obey the controls of their human overlords, whether misbehaving cancer cells or therapeutic-producing CHO cells.

 

B2B

1 to 25

Seed

N/A

Scaling Up

2014

 
 

Biotechnology

N/A

N/A

 
 

Service

Yes

Active

 
 

   Machine Learning


Health Care Systems

Health Care Systems

SPF

SPF


N/A

 

   Software


N/A


N/A

 
 

View All

Research Associate (full-time)

Oakland, California

 

AI/ML Professionals

Want to work at Circularis Biotechnologies?

We can introduce you to the right person at Circularis Biotechnologies

Talk to our Talent Team

 
Mat Falkowski


Mat Falkowski
CEO

LeAnn Lindsay


LeAnn Lindsay
Co-founder, Senior Scientist

Paul Feldstein


Paul Feldstein
Chief Scientific Officer

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Circularis Biotechnologies